PTPRC and acute myeloid leukemia: Interestingly, concerning the AML mouse model only in mice injected with the signaling ECAR about half of human CD45+ cells detected in the bone marrow are T cells, whereas in the two other groups treated with vector control or ECAR Stop modified T cells percentage of CD3+ cells is in the range of background noise observed in the control group treated only with AML cells but without T cells (Fig. S1e).